HK Stock Market Move | CHINA RISUN GP(01907) up nearly 4% Middle East situation disrupts energy landscape, company's chemical industry sector expected to contribute to earnings flexibility.

CHINA RISUN GP (01907) rose by nearly 4% as of the time of publication, with an increase of 3.95%, closing at 3.16 Hong Kong dollars with a trading volume of 1.14 billion Hong Kong dollars. On the news front, the continued turmoil in the Middle East is disrupting the global energy and chemical supply chain. Debon Securities believes that looking ahead to 2026, the ongoing Middle East geopolitical crisis will drive a substantial increase in international crude oil prices, and the company's chemical business will also see a simultaneous significant increase in prices (such as methanol and caprolactam, with market prices at the end of March rising by over 60% and 30% respectively compared to the beginning of the year). The company's years of planning may lead to a period of substantial harvest. Furthermore, on April 2, CHINA RISUN GP announced on its official WeChat public account that its independently developed caprolactam to hexamethylene diamine unit completed catalyst filling on March 30, 2026, laying the foundation for production in April. It is expected to produce approximately 30,000 tons in the full year of 2026.